The effects of α₁-acid glycoprotein on the reversal of chloroquine resistance in Plasmodium falciparum

REFERENCES

• Bitonti, A. J., Sjoendoma, A., McCann, P. P., Kyle, D. E., Oduola, A. M. J., Rossan, R. N., Milhous, W. K & Davidson, D. E. (1988). Reversal of chloroquine in the malaria parasite Plasmodium falciparum by desipramine. Science, 242,1303-1305.
   Google Scholar
• Bloland, P. B., Ettling, M. & Meek, S. (2000). Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization, 78, 1378–1388.
   PubMed Web of Science ®Google Scholar
• Bloland, P. B., Kachur, S. P. & Williams, H. A. (2003). Trends in antimalarial drug deployment in sub-Saharan Africa. Journal of Experimental Biology, 206, 3761-3769.
   Google Scholar
• Boulter, M. K., Bray, P. G., Howells, R E. & Ward, S. A. (1993). The potential of desipramine to reverse chloroquine resistance of Plasmodium falciparum is reduced by its binding to plasma proteins. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87,303.
   PubMed Web of Science ®Google Scholar
• Desjardins, R E., Canfield, C. J., Haynes, J. D. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710–718.
   PubMed Web of Science ®Google Scholar
• Haynes, J. D., Diggs, C. L., Hines, F. A. & Desjardins, R. E. (1976). Culture of human malaria parasites, Plasmodium falciparum. Nature, 263, 767–769.
   PubMed Web of Science ®Google Scholar
• Kaliszan, R., Nasal, A. & Turowski, M. (1995). Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data. Biomedical Chromatography, 9, 211–215.
   PubMed Web of Science ®Google Scholar
• Kokue, S. M., On, E., Hariya, D. S. & Shimoda, S. (1996). Contribution of alpha 1-acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs. Journal of Veterinary Pharmacology and Therapeutics, 19, 176–183.
   PubMed Web of Science ®Google Scholar
• Kyle, D. E., Oduola, A. M., Martin, S. K. & Milhous, W. K. (1990). Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethychloroquine, quinine, and quinidine in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 474-478.
   Google Scholar
• Levy, R. H. & Moreland, T. A. (1984). Rationale for monitoring free drug levels. Clinical Pharmacokinetics, 9, 1-9.
   Google Scholar
• Martin, S. K., Oduola, A. M. J. & Milhous, W. K. (1987). Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science, 235, 899-901.
   Google Scholar
• Mberu, E. K., Mosobo, M. K., Nzila, A. M., Kokwaro, G. O., Sibley, C. H. & Watkins, W. M. (2000). The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. American Journal of Tropical Medicine and Hygiene, 62,396–401.
   PubMed Web of Science ®Google Scholar
• Mutabingwa, T. K., Anthony, D., Heller, A., Hallett, R., Ahmed, J., Drakeley, C., Greenwood, B. M. & Whitty, C. J. (2005). Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine + artesunate, and artemether-lumefantrine for out-patient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet, 365,1474-1480.
   Google Scholar
• Nzila, A., Mberu, E., Bray, P., Kokwaro, G., Winstanley, P., Marsh, K. & Ward, S. (2003). Chemosensitization of Plasmodium falciparum by probenecid. Antimicrobial Agents and Chemotherapy, 47,2108–2112.
   PubMed Web of Science ®Google Scholar
• Oduola, A. M. J., Weatherly, N. F., Browdre, J. H. & Desjardins, R. E. (1988). Plasmodium falciparum: cloning by single erythrocyte micromanipulation and heterogeneity in vitro. Experimental Parasitology, 66, 86–95.
   Google Scholar
• Oduola, A. M. J., Omitowoju, G. O., Gerena, L., Kyle, D. E., Milhous, W. K., Sowunmi, A. & Salako, L. A. (1993). Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 81-83.
   Google Scholar
• Oduola, A. M. J., Sowunmi, A., Milhous, W. K., Brewer, T. G., Kyle, D. E., Gerena, L., Rossan, R. N., Salako, L. A. & Schuster, B. G. (1998). In vitro and in vitro reversal of chloroquine resistance in Plasmodium falciparum with promethazine. American Journal of Tropical Medicine and Hygiene, 58, 625–629.
   PubMed Web of Science ®Google Scholar
• Omitowoju, G. O., Ogundahunsi, O. A. T., Milhous, W. K., Gerena, L., Sowunmi, A., Schuster, B. G. & Oduola, A. M. J. (1992). Chlorpheniramine: a resistance reversing agent with potential clinical application. American Journal of Tropical Medicine and Hygiene, 47 (Suppl.), 175.
   Google Scholar
• Peters, W., Ekong, R., Robinson, B. L., Warhurst, D. C. & Pan, X. Q. (1989). Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falci-parum. Lancet, ii, 334-335.
   Google Scholar
• Routledge, P. A. (1986). The plasma protein binding of basic drugs. British Journal of Clinical Pharmacology, 22,499–506.
   PubMed Web of Science ®Google Scholar
• Son, D. S., Hariya, S., Shimoda, M. & Kokue, E (1996). Contribution of alpha 1-acid glycoprotein to plasma protein binding of some basic antimicrobials in pigs. Journal of Veterinary Pharmacology and Therapeutics, 19, 176–183.
   PubMed Web of Science ®Google Scholar
• Sowunmi, A. & Oduola, A. M. J. (1998). Viability of Plasmodium falciparum ex vivo: comparison of the effects of artemether and sulfadoxine-pyrimetha-mine. European Journal of Clinical Pharmacology, 54, 221–226.
   PubMed Web of Science ®Google Scholar
• Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T., Falade, C. O., Gbotosho, G. O. & Salako, L. A. (1997). Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncompli-cated falciparum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 63–67.
   PubMed Web of Science ®Google Scholar
• Sowunmi, A., Adedeji, A. A., Fateye, B. A. & Fehintola, F. A. (2004). Comparative effects of pyrimethamine-sulfadoxine, with and without pro-benecid, on Plasmodium falciparum gametocytes in children with acute, uncomplicated malaria. Annals of Tropical Medicine and Parasitology, 98, 873–878.
   PubMed Web of Science ®Google Scholar
• Sutherland, C. J., Ord, R., Dunyo, S., Jawara, M., Drakeley, C. J., Alexander, N., Coleman, R., Pinder, M., Walraven, G. & Targett, G. A. (2005). Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Medicine, 2, e92.
   PubMed Web of Science ®Google Scholar
• Suzuki, Y., Sugiyama, Y., Sawada, Y., Iga, T. & Hanano, M. (1985). Assessment of the contribution of alpha-1 -acid glycoprotein to the serum binding of basic drugs using serum treated with sulphosalicyclic acid and DEAE-cellulose. Journal of Pharmacy and Pharmacology, 37,712–717.
   PubMed Web of Science ®Google Scholar
• Trager, W. & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science, 193, 673–675.
   PubMed Web of Science ®Google Scholar
• Trape, J. F. (2001). The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene, 64, 12–17.
   PubMed Web of Science ®Google Scholar
• Warsame, M., Wernsdorfer, W. H. & Björkman, A. (1992). Lack of effect of desipramine on the response to chloroquine in patients with chloroquine-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 235-236.
   Google Scholar
• White, N. J. (1998). Why is it that antimalarial drug treatments do not work? Annals of Tropical Medicine and Parasitology, 92, 449–458.
   PubMed Web of Science ®Google Scholar